Brokerages expect Genpact Limited (NYSE:G) to report sales of $761.50 million for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Genpact’s earnings, with estimates ranging from $755.29 million to $774.96 million. Genpact posted sales of $708.82 million during the same quarter last year, which would indicate a positive year over year growth rate of 7.4%. The firm is scheduled to issue its next quarterly earnings report after the market closes on Tuesday, November 6th.
According to Zacks, analysts expect that Genpact will report full year sales of $2.98 billion for the current year, with estimates ranging from $2.96 billion to $3.00 billion. For the next year, analysts expect that the business will report sales of $3.23 billion, with estimates ranging from $3.19 billion to $3.29 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that cover Genpact.
Genpact (NYSE:G) last issued its quarterly earnings data on Tuesday, August 7th. The business services provider reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. Genpact had a net margin of 9.44% and a return on equity of 22.15%. The firm had revenue of $728.56 million for the quarter, compared to the consensus estimate of $734.51 million.
A number of brokerages have recently issued reports on G. Zacks Investment Research downgraded shares of Genpact from a “hold” rating to a “sell” rating in a research report on Tuesday, October 9th. Cantor Fitzgerald reiterated a “buy” rating and issued a $36.00 target price on shares of Genpact in a research note on Wednesday, August 8th. SunTrust Banks reiterated a “buy” rating and issued a $37.00 target price on shares of Genpact in a research note on Thursday, August 9th. Finally, JPMorgan Chase & Co. cut shares of Genpact from a “neutral” rating to an “underweight” rating and set a $37.00 target price for the company. in a research note on Tuesday, August 14th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company’s stock. Genpact presently has an average rating of “Hold” and an average price target of $36.50.
Shares of Genpact stock traded up $0.07 on Tuesday, reaching $28.92. The stock had a trading volume of 2,565 shares, compared to its average volume of 745,043. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.76. Genpact has a 1 year low of $27.67 and a 1 year high of $34.79. The company has a market cap of $5.52 billion, a P/E ratio of 19.45, a PEG ratio of 1.86 and a beta of 0.55.
The business also recently announced a quarterly dividend, which was paid on Wednesday, September 19th. Investors of record on Monday, September 10th were paid a $0.075 dividend. This represents a $0.30 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date was Friday, September 7th. Genpact’s dividend payout ratio (DPR) is presently 20.13%.
In other Genpact news, Director Carol Lindstrom sold 2,630 shares of Genpact stock in a transaction that occurred on Friday, August 17th. The shares were sold at an average price of $30.44, for a total transaction of $80,057.20. Following the completion of the sale, the director now directly owns 17,141 shares in the company, valued at approximately $521,772.04. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Heather White sold 1,367 shares of Genpact stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $31.00, for a total transaction of $42,377.00. The disclosure for this sale can be found here. 1.41% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in G. First Hawaiian Bank purchased a new position in shares of Genpact during the 3rd quarter valued at approximately $109,000. Fort L.P. purchased a new position in shares of Genpact during the 2nd quarter valued at approximately $116,000. Contravisory Investment Management Inc. purchased a new position in shares of Genpact during the 2nd quarter valued at approximately $130,000. SRS Capital Advisors Inc. increased its holdings in shares of Genpact by 88.6% during the 2nd quarter. SRS Capital Advisors Inc. now owns 4,820 shares of the business services provider’s stock valued at $139,000 after purchasing an additional 2,264 shares in the last quarter. Finally, Point72 Hong Kong Ltd increased its holdings in shares of Genpact by 286.9% during the 2nd quarter. Point72 Hong Kong Ltd now owns 6,001 shares of the business services provider’s stock valued at $174,000 after purchasing an additional 4,450 shares in the last quarter. Institutional investors and hedge funds own 88.53% of the company’s stock.
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; over-the counter services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.
Featured Story: Return on Investment (ROI)
Get a free copy of the Zacks research report on Genpact (G)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.